Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hasan Hashem

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|April 1, 2026
Twelve-year utilization and outcomes of haploidentical hematopoietic stem cell transplantation (HSCT) in the Eastern Mediterranean (EM) region: A multicenter EMBMT registry analysisJean El Cheikh, Ali Tarhini, Ali Bazarbachi, et al.
Blood|October 5, 2017
Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2Hasan Hashem, Ashish R Kumar, Ingo Müller, et al.
Transplantation and Cellular Therapy|November 28, 2022
Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant DiseasesLarisa Broglie, Brian D Friend, Saurabh Chhabra, et al.
Transplantation and Cellular Therapy|November 28, 2022
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell TransplantationBrian D Friend, Larisa Broglie, Brent R Logan, et al.
Blood Advances|December 12, 2025
Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant RecipientsMiki Nishitani, Rudi-Ann Tamara Graham, Tao Wang, et al.
Blood|March 16, 2025
HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective studyQuentin Riller, Mathias Hauri, Su Han Lum, et al.
Transplantation and Cellular Therapy|March 15, 2021
Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseCaitlin W Elgarten, Yimei Li, Kelly D Getz, et al.
Transplantation and Cellular Therapy|March 29, 2023
Effect of Autograft CD34<sup>+</sup> Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System TumorsTristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Transplantation and Cellular Therapy|July 21, 2022
Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic MalignancyCatherine J Lee, Tao Wang, Karen Chen, et al.
Transplantation and Cellular Therapy|March 22, 2022
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Kwang Woo Ahn, Manoj Khanal, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|April 1, 2026
Twelve-year utilization and outcomes of haploidentical hematopoietic stem cell transplantation (HSCT) in the Eastern Mediterranean (EM) region: A multicenter EMBMT registry analysisJean El Cheikh, Ali Tarhini, Ali Bazarbachi, et al.
Blood|October 5, 2017
Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2Hasan Hashem, Ashish R Kumar, Ingo Müller, et al.
Transplantation and Cellular Therapy|November 28, 2022
Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant DiseasesLarisa Broglie, Brian D Friend, Saurabh Chhabra, et al.
Transplantation and Cellular Therapy|November 28, 2022
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell TransplantationBrian D Friend, Larisa Broglie, Brent R Logan, et al.
Blood Advances|December 12, 2025
Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant RecipientsMiki Nishitani, Rudi-Ann Tamara Graham, Tao Wang, et al.
Blood|March 16, 2025
HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective studyQuentin Riller, Mathias Hauri, Su Han Lum, et al.
Transplantation and Cellular Therapy|March 15, 2021
Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseCaitlin W Elgarten, Yimei Li, Kelly D Getz, et al.
Transplantation and Cellular Therapy|March 29, 2023
Effect of Autograft CD34<sup>+</sup> Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System TumorsTristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Transplantation and Cellular Therapy|July 21, 2022
Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic MalignancyCatherine J Lee, Tao Wang, Karen Chen, et al.
Transplantation and Cellular Therapy|March 22, 2022
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Kwang Woo Ahn, Manoj Khanal, et al.
Pageof 6